Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07456371 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PIC1 Injection Therapy for Relapsed/Refractory B-NHL

Name: PIC1 Injection Therapy for Relapsed/Refractory B-NHL — clinical trial record (NCT07456371)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 1

SponsorChongqing Precision Biotech Co., Ltd

Started2026-03

View on ClinicalTrials.gov ↗

Chongqing Precision Biotech Co., Ltd

36 trials monitored

See 1 trial at risk

Non-Hodgkin Lymphoma

1,512 trials monitored

See 79 trials at risk

This is an investigator-initiated trial aimed at assessing the safety and efficacy of PIC1 injection in the treatment of relapsed/refractory B-cell Non-Hodgkin Lymphoma.

Trial Details

NCT Number	NCT07456371
Lead Sponsor	Chongqing Precision Biotech Co., Ltd
Conditions	Non-Hodgkin Lymphoma
Enrollment	18 participants
Start Date	2026-03
Primary Completion	2026-12 (estimated)
Study Completion	2029-02 (estimated)
Updated on ClinicalTrials.gov	2026-03-06